295 Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

Yufei Wang(Fujian Medical University), Wayne A. Marasco(Dana-Farber Cancer Institute), Maura Sticco-Ivins(Brigham and Women's Hospital), Martin Hemberg(Brigham and Women's Hospital), David Braun(Yale University), Audrey Apollon(Dana-Farber Cancer Institute), Cecile Razimbaud(Dana-Farber Cancer Institute), Sabina Signoretti(Brigham and Women's Hospital), Catherine J. Wu(Dana-Farber Cancer Institute), Alicia Buck(Unknown), Brandon Piel(Dana-Farber Cancer Institute), Toni K. Choueiri(Harvard University), Michael Lynch(Indiana University Bloomington), Miriam Ficial(Barts Health NHS Trust), Rebecca B. Jennings(IHS Markit (United States)), Cloud P. Paweletz(Massachusetts General Hospital), David A. Barbie(Dana-Farber Cancer Institute), Kristen L. Jones(Oregon Health & Science University), Marion Grimaud(Dana-Farber Cancer Institute), Jae-Won Cho(Brigham and Women's Hospital), Gordon J. Freeman(Dana-Farber Cancer Institute), Quang‐Dé Nguyen(Dana-Farber Cancer Institute), Jon O. Wee(Brigham and Women's Hospital), Dennis M. Bonal(Dana-Farber Cancer Institute), Luann Zerefa(Dana-Farber Cancer Institute), Aedín C. Culhane(Harvard University), Gabriella Kastrunes(Dana-Farber Cancer Institute), Zhu Zhu(Soochow University), Elena P. Ivanova(RMIT University), Kevin Wei(Harvard University Press), Matthew Chang(Dana-Farber Cancer Institute), Atef Fayed(Georgetown University), Zehua Li(Dana-Farber Cancer Institute)
Regular and Young Investigator Award Abstracts
November 1, 2022
Cited by 3


Related Papers